Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruben A. Mesa
Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Safety and Efficacy of the Maximum Tolerated Dose of Givinostat in Polycythemia Vera: A Two-Part Phase Ib/Ii Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-Controlled, Phase III Study in Patients With Myelofibrosis
British Journal of Haematology
Hematology
A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis
British Journal of Haematology
Hematology
Incidence and Outcomes of Primary Engraftment Failure in Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Ruxolitinib for Myelofibrosis–An Update of Its Clinical Effects
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Neutrophil PRV-1 Expression Across the Chronic Myeloproliferative Disorders and in Secondary or Spurious Polycythemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
MPL515 Mutations in Myeloproliferative and Other Myeloid Disorders: A Study of 1182 Patients
Blood
Biochemistry
Immunology
Cell Biology
Hematology